Graft-Versus-Host Disease

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

A Study of Ruxolitinib in Patients With Graft-Versus Host Disease

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Pomalidomide for Chronic Graft-versus-Host Disease

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease

Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease

Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

Safety and Efficacy of Fecal Microbiota Transplantation

Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT